Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro

A singlet oxygen dose model is developed for PDT with Photofrin. The model is based on photosensitizer photobleaching kinetics, and incorporates both singlet oxygen and non-singlet oxygen mediated bleaching mechanisms. To test our model, in vitro experiments were performed in which MatLyLu (MLL) cells were incubated in Photofrin and then irradiated with 532 nm light. Photofrin fluorescence was monitored during treatment and, at selected fluence levels, cell viability was determined using a colony formation assay. Cell survival correlated well to calculated singlet oxygen dose, independent of initial Photofrin concentration or oxygenation. About 2 x 10(8) molecules of singlet oxygen per cell were required to reduce the surviving fraction by 1/e. Analysis of the photobleaching kinetics suggests that the lifetime of singlet oxygen in cells is 0.048 +/- 0.005 micros. The generation of fluorescent photoproducts was not a result of singlet oxygen reactions exclusively, and therefore did not yield additional information to aid in quantifying singlet oxygen dose.

[1]  Michael S Patterson,et al.  Direct Near-infrared Luminescence Detection of Singlet Oxygen Generated by Photodynamic Therapy in Cells In Vitro and Tissues In Vivo¶ , 2002, Photochemistry and photobiology.

[2]  J Moan,et al.  The Biophysical Foundations of Photodynamic Therapy , 1998, Endoscopy.

[3]  S. Mitra,et al.  Photodynamic therapy: Biophysical mechanisms and molecular responses , 2004 .

[4]  J Moan,et al.  The binding of dihematoporphyrin ether (photofrin II) to human serum albumin. , 1985, Clinica chimica acta; international journal of clinical chemistry.

[5]  K. Berg,et al.  THE PHOTODEGRADATION OF PORPHYRINS IN CELLS CAN BE USED TO ESTIMATE THE LIFETIME OF SINGLET OXYGEN , 1991, Photochemistry and photobiology.

[6]  A. Douplik,et al.  Oxygen consumption and photobleaching in whole blood incubated with photosensitizer induced by laser irradiation , 2003 .

[7]  W. Potter,et al.  PHOTOBLEACHING OF PHOTOFRIN II AS A MEANS OF ELIMINATING SKIN PHOTOSENSITIVITY * , 1987, Photochemistry and photobiology.

[8]  M G Nichols,et al.  The Mechanism of Photofrin Photobleaching and Its Consequences for Photodynamic Dosimetry , 1997, Photochemistry and photobiology.

[9]  J. Spikes.  QUANTUM YIELDS AND KINETICS OF THE PHOTOBLEACHING OF HEMATOPORPHYRIN, PHOTOFRIN II, TETRA(4‐SULFONATOPHENYL)‐PORPHINE AND UROPORPHYRIN , 1984 .

[10]  T. Foster,et al.  Singlet Oxygen‐Versus Nonsinglet Oxygen‐Mediated Mechanisms of Sensitizer Photobleaching and Their Effects on Photodynamic Dosimetry , 1998, Photochemistry and photobiology.

[11]  K. Berg,et al.  Comparison of the photobleaching effect of three photosensitizing agents: Meso-tetra(m-hydroxyphenyl)chlorin, meso-tetra(m-hydroxyphenyl)porphyrin and photofrin during photodynamic therapy , 1994, Lasers in Medical Science.

[12]  Michele T. Cooper,et al.  Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate. , 2000, Cancer research.

[13]  L. Grossweiner,et al.  Singlet oxygen generation by Photofrin in homogeneous and light-scattering media. , 1994, Journal of photochemistry and photobiology. B, Biology.

[14]  R. Redmond,et al.  Can Cellular Phototoxicity be Accurately Predicted on the Basis of Sensitizer Photophysics? , 1999, Photochemistry and photobiology.

[15]  T J Dougherty,et al.  Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. , 1976, Cancer research.

[16]  K König,et al.  Variation in the fluorescence decay properties of haematoporphyrin derivative during its conversion to photoproducts. , 1990, Journal of photochemistry and photobiology. B, Biology.

[17]  J. Moan,et al.  PHOTOINDUCED DEGRADATION AND MODIFICATION OF PHOTOFRIN II IN CELLS in vitro , 1988, Photochemistry and photobiology.

[18]  M R Arnfield,et al.  Oxygen dependency of tumor cell killing in vitro by light-activated Photofrin II. , 1991, Radiation research.

[19]  T. Dougherty,et al.  An Assay for the Quantitation of Photofrin in Tissues and Fluids , 1997, Photochemistry and photobiology.

[20]  J F Fowler,et al.  DIFFERENCES IN SURVIVAL CURVE SHAPES FOR FORMAL MULTI-TARGET AND MULTI-HIT MODELS , 1964 .

[21]  T J Dougherty,et al.  Energetics and efficiency of photoinactivation of murine tumor cells containing hematoporphyrin. , 1976, Cancer research.

[22]  Michael S. Patterson,et al.  Calculation of Singlet Oxygen Dose from Photosensitizer Fluorescence and Photobleaching During mTHPC Photodynamic Therapy of MLL Cells¶ , 2005 .

[23]  R. Redmond,et al.  A Compilation of Singlet Oxygen Yields from Biologically Relevant Molecules , 1999, Photochemistry and photobiology.

[24]  Q. Peng,et al.  PHOTOSENSITIZING EFFICIENCIES, TUMOR‐ and CELLULAR UPTAKE OF DIFFERENT PHOTOSENSITIZING DRUGS RELEVANT FOR PHOTODYNAMIC THERAPY OF CANCER , 1987, Photochemistry and photobiology.

[25]  T. Dougherty,et al.  HOW DOES PHOTODYNAMIC THERAPY WORK? , 1992, Photochemistry and photobiology.

[26]  C. Koch,et al.  Prognostic significance of tumor oxygenation in humans. , 2003, Cancer letters.

[27]  Jarod C Finlay,et al.  Photobleaching kinetics of Photofrin in vivo and in multicell tumour spheroids indicate two simultaneous bleaching mechanisms. , 2004, Physics in medicine and biology.

[28]  J Moan,et al.  A COMPARISON OF THREE PHOTOSENSITIZERS WITH RESPECT TO EFFICIENCY OF CELL IN ACTIVATION, FLUORESCENCE QUANTUM YIELD AND DNA STRAND BREAKS , 1990, Photochemistry and photobiology.

[29]  M G Nichols,et al.  Oxygen diffusion and reaction kinetics in the photodynamic therapy of multicell tumour spheroids. , 1994, Physics in medicine and biology.

[30]  J Moan,et al.  PHOTOBLEACHING OF PORPHYRINS USED IN PHOTODYNAMIC THERAPY AND IMPLICATIONS FOR THERAPY , 1987, Photochemistry and photobiology.